QIAGEN CLC Genomics Workbench is a powerful solution to analyze and visualize next generation sequencing (NGS) data. Powered by cutting-edge technology and accelerated algorithms, it supports a ...

New innovative product launches at American Association for Cancer Research (AACR) Annual Meeting add to broad portfolio of NGS solutions High-speed QIAxpert accelerates quantification and quality ...

Venlo, the Netherlands, and San Diego, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic ...

It strengthens QIAGEN’s rapidly emerging portfolio of “universal” products that can be used with any NGS sequencer as well as providing a key element to the portfolio of automated solutions for the ...

“Adoption of QIAGEN's universal bioinformatics solutions is growing rapidly as we continue to integrate and expand the capabilities of our applications and knowledge bases from CLC bio, Ingenuity and ...

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications. QIAGEN ...

QIAGEN and Element Biosciences say they have entered a strategic partnership to offer next-generation sequencing (NGS) workflows for the Element AVITI™ benchtop system. For customers using the AVITI ...

CLC Cancer Research Workbench is the world's first comprehensive, user-friendly and customizable cancer-focused NGS bioinformatics solution QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) ...

Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...